BioHarvest Sciences Inc.

Recent News

  • BioHarvest Sciences Unveils Profile of Unique Cannabis Composition

    Full spectrum profile to include major and minor Cannabinoids as well as TerpenesUnique trichome structure provides for potentially higher solubility and bio-availability With Trichomes representing 93% of the Cannabis biomass produced using the proprietary Bio-Plant CELLicitation™ technology, taste bitterness is significantly reducedVancouver, Canada, and Rehovot, Israel--(Newsfile Corp. - May 12, 2022) - BioHarvest Sciences Inc. the (CSE: BHSC) ("BioHarvest" or the "company") today unveiled the composition profile of its full-spectrum Cannabis produced in large-scale industrial bioreactors based on its proprietary Bio-Plant...

    2022-05-12 7:00 AM EDT
  • BioHarvest Sciences Inc. Announces a Private Placement of up to USD $5 Million of Convertible Notes to Finance Production Facilities and Scaling of Core Business

    Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - April 7, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC:CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") announced today a financing plan based on a private placement of up to USD $5 Million (approximately $6.3 Million CAD). The funds raised will allow the Company to accelerate the growth plan for its polyphenols/antioxidants and Cannabis verticals.On March 23, 2021, BHSC announced the completion of the Company's Cannabis R&D program, marking the start of the proposed...

    2022-04-07 7:30 AM EDT
  • Bioharvest Sciences Inc. Reports Strong Q1 2022 Results on All of the Company's Activities

    VINIA® sales orders grew 112% compared to Q1 2021 to reach USD 787k Reiterating guidance for year-on-year sales orders growth of 2.5-3.5X to reach USD 5M - 7MStarted the transition of VINIA® production at new 20 tons/year facility enabling the scaling of VINIA® sales and conversion of current 2 tons/year facility to CannabisProduced a unique Cannabis composition in large industrial scale Bioreactors enabling the commercialization and sales of Cannabis products in H2 2022Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. -...

    2022-04-06 7:30 AM EDT
  • Bioharvest Sciences Inc. Successfully Completes Cannabis R&D Program

    Now producing Cannabis biomass in large scale industrial bioreactors under the current R&D license.Commencing the process of transitioning the current Israeli Cannabis R&D license to a production license.Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 23, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") today announced that it has produced Cannabis Biomass in large scale industrial bioreactors, which represents the completion of the Company's Cannabis R&D program.On December 8th, 2021, BHSC became the first company ever to...

    2022-03-23 7:00 AM EDT
  • BioHarvest Sciences Inc. Quarterly Shareholder Update Live Event April 7, 2022, at 2:00 PM E.T.

    Vancouver, British Columbia, and Rehovot, Israel--(Newsfile Corp. - March 11, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or "the Company") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, April 7, 2022, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time).BioHarvest Sciences CEO Ilan Sobel will host the event, which will include an unveiling of the 2022 Growth Priorities, including a detailed performance update on the commercialization of the...

    2022-03-11 7:00 AM EST
  • BioHarvest Sciences Inc. Trademarks Its Breakthrough Non-GMO Proven Platform Technology: "BIO-PLANT CELLicitation"

    Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 16, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or "the Company") has announced the new trademark for its proprietary non-GMO Biotech platform technology. The new name, "Bio-Plant CELLicitation™," replaces "BioFarming" and underscores the potential for the technology to be used in the botanical drugs space."The Bio-Plant CELLicitation™ proven platform technology allows us to address multiple market verticals with multiple products under different categories," said CEO Ilan Sobel. "The elicitation element allowing the...

    2022-02-16 5:55 AM EST
  • BioHarvest Sciences Inc. Engages Thunder11 as a Public Relations Agency of Record

    Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 10, 2022) -  BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) (FSE:8MV) ("BioHarvest" or "the Company") a fast-growing Biotech firm listed on the Canadian Securities Exchange, has engaged the award winning New York City-based communications firm Thunder11 for Public Relations services.Thunder11, which has specializations in technology, healthcare, and public affairs, will be involved in raising BioHarvest's profile with media relations, partners, and other influential audiences. BioHarvest joins a rost

    2022-02-10 5:55 AM EST
  • BioHarvest Sciences Inc. to Present at BIO CEO & Investor Conference in New York City on February 14-17, 2022

    Vancouver, British Columbia, and Rehovot, Israel--(Newsfile Corp. - February 3, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or "the Company") is pleased to announce that it has been selected as a presenter at the upcoming BIO CEO & Investor Conference, hosted by the Biotechnology Innovation Organization in New York City on Feb 14-17. CEO Ilan Sobel will deliver a virtual presentation and will conduct investor meetings and industry networking by remote at the event, which this year...

    2022-02-03 5:55 AM EST